Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (TSX: NUMI ) 0.0300 +0.0050 (+20.00%) Streaming Delayed Price Updated: 3:21 PM EDT, Oct 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 596,985 Open 0.0300 Bid (Size) 0.0250 (18,050) Ask (Size) 0.0300 (7,690) Prev. Close 0.0250 Today's Range 0.0250 - 0.0300 52wk Range 0.0250 - 0.2000 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psychedelics Co. Numinus Narrows Loss In Q3, Reports QoQ Decrease In Revenue, Gross Profit July 12, 2024 Psychedelics-focused mental health care company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), announced on Thursday its third quarter financial results for the three months ended May 31, 2024."In... Via Benzinga Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition June 22, 2024 Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) plans to take over MedBright AI Investments Inc. (CSE: MBA).The proposed transaction comes as... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Performance YTD -75.00% -75.00% 1 Month N/A N/A 3 Month -40.00% -40.00% 6 Month -57.14% -57.14% 1 Year -81.25% -81.25% More News Read More Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate November 30, 2023 Via Benzinga Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031 July 26, 2023 Via FinancialNewsMedia Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing July 14, 2023 From Virtual Investor Conferences Via GlobeNewswire Small Cap Growth Virtual Investor Conference Agenda Announced for July 13th July 10, 2023 From Virtual Investor Conferences Via GlobeNewswire The Power Play by The Market Herald Releases New Interviews with Justera Health, Nextech3D.ai, Numinus Wellness, Sona Nanotech and Fineqia International Discussing Their Latest News June 08, 2023 Via ACCESSWIRE The Power Play by The Market Herald Releases New Interviews with Reunion Gold Corp, Numinus Wellness, Core Assets, Blockmate Ventures, BioVaxys Tech, Carlyle Commodities and Belmont Resources Discussing Their Latest News April 18, 2023 Via ACCESSWIRE Healing CREI Announces a Partnership with Numinus Wellness Inc. April 11, 2023 Via Newsfile Numinus Expands Research Capabilities with new Phoenix Clinical Research Site February 17, 2023 Via PressReach Numinus Wellness Inc. Reports Q1 2023 Results January 17, 2023 Via PressReach KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing December 16, 2022 From Virtual Investor Conferences Via GlobeNewswire KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th December 13, 2022 From Virtual Investor Conferences Via GlobeNewswire Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research December 08, 2022 Via PressReach Alberta Becomes the First Province to Regulate Psychoactives for Therapeutic Purposes November 30, 2022 Via PressReach Topics Law Enforcement Exposures Legal Numinus Wellness Inc. Reports Q4 2022 and Annual Results November 30, 2022 Via PressReach Colorado Has Just Legalized The Use of Magic Mushrooms November 23, 2022 Via PressReach Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness October 28, 2022 Via PressReach New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences October 05, 2022 Via PressReach Topics Supply Chain Exposures Supply Chain Colorado to Vote on Legalizing Psychoactives in November October 05, 2022 Via PressReach Topics Supply Chain Exposures Supply Chain Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease October 05, 2022 Via PressReach Topics Cannabis Exposures Cannabis New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences October 05, 2022 Via FinancialNewsMedia Mental Health Claims up 75% Since 2019 September 23, 2022 Via PressReach Mental Health Claims up 75% Since 2019 September 23, 2022 Via FinancialNewsMedia Numinus Opens New Clinic in Montreal to Increase Access to Ketamine Therapy for Mental Health September 22, 2022 Via PressReach Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.